These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 15879763)

  • 1. Benign prostatic hyperplasia: patient perceptions and financial reality regarding the aging American prostate.
    Kaplan SA
    J Urol; 2005 Jun; 173(6):1852. PubMed ID: 15879763
    [No Abstract]   [Full Text] [Related]  

  • 2. A clinical outcomes and cost analysis comparing photoselective vaporization of the prostate to alternative minimally invasive therapies and transurethral prostate resection for the treatment of benign prostatic hyperplasia.
    Stovsky MD; Griffiths RI; Duff SB
    J Urol; 2006 Oct; 176(4 Pt 1):1500-6. PubMed ID: 16952668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Durability and cost-effectiveness of transurethral needle ablation of the prostate as an alternative to transurethral resection of the prostate when alpha-adrenergic antagonist therapy fails.
    Rosario DJ; Phillips JT; Chapple CR
    J Urol; 2007 Mar; 177(3):1047-51; discussion 1051. PubMed ID: 17296409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The management of benign prostatic obstruction: a voice from the Third World.
    Sharma DP
    BJU Int; 2006 Apr; 97(4):671-2. PubMed ID: 16536748
    [No Abstract]   [Full Text] [Related]  

  • 5. Transurethral resection vs microwave thermotherapy of the prostate: a cost-consequences analysis.
    Gordon NS
    BJU Int; 2004 May; 93(7):1118-9. PubMed ID: 15142185
    [No Abstract]   [Full Text] [Related]  

  • 6. Benign prostatic obstruction and parkinson's disease--should transurethral resection of the prostate be avoided?
    Roth B; Studer UE; Fowler CJ; Kessler TM
    J Urol; 2009 May; 181(5):2209-13. PubMed ID: 19296974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Benign overgrowth of the prostate].
    Duodecim; 2006; 122(1):107-8. PubMed ID: 16509199
    [No Abstract]   [Full Text] [Related]  

  • 8. Prostate cancer: sometimes it pays to do nothing.
    Smith MD; McGhan WF
    Bus Health; 1997 Jan; 15(1):42-3. PubMed ID: 10164138
    [No Abstract]   [Full Text] [Related]  

  • 9. Benign prostatic hyperplasia: counting the cost of its management.
    Kirby RS; Kirby M; Fitzpatrick JM
    BJU Int; 2010 Apr; 105(7):901-2. PubMed ID: 20356323
    [No Abstract]   [Full Text] [Related]  

  • 10. A cost comparison of medical management and transurethral needle ablation for treatment of benign prostatic hyperplasia during a 5-year period.
    Naslund MJ; Carlson AM; Williams MJ
    J Urol; 2005 Jun; 173(6):2090-3; discussion 2093. PubMed ID: 15879849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Some aspects of transurethral resection of large benign prostatic hyperplasia].
    Managadze LG; Khvadagiani GG; Abdushelishvili KO; Managadze GL; Berulava DT
    Georgian Med News; 2007 Feb; (143):53-7. PubMed ID: 17404441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and external validation of a highly accurate nomogram for the prediction of perioperative mortality after transurethral resection of the prostate for benign prostatic hyperplasia.
    Jeldres C; Isbarn H; Capitanio U; Zini L; Bhojani N; Shariat SF; Cloutier V; Lattouf JB; Duclos A; Jolivet-Tremblay M; Valiquette L; Saad F; Graefen M; Montorsi F; Perrotte P; Karakiewicz PI
    J Urol; 2009 Aug; 182(2):626-32. PubMed ID: 19535100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of standard transurethral resection, transurethral vapour resection and holmium laser enucleation of the prostate for managing benign prostatic hyperplasia of >40 g.
    Gupta N; Sivaramakrishna ; Kumar R; Dogra PN; Seth A
    BJU Int; 2006 Jan; 97(1):85-9. PubMed ID: 16336334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rotoresection versus transurethral resection of the prostate: short-term evaluation of a prospective randomized study.
    Soliman SA; Wadie BS; Ibrahim el-HE; Shehab El-Dein AB
    J Urol; 2007 Mar; 177(3):1036-9. PubMed ID: 17296407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insurance and quality of life in men with prostate cancer: data from the Cancer of the Prostate Strategic Urological Research Endeavor.
    Sadetsky N; Lubeck DP; Pasta DJ; Latini DM; DuChane J; Carroll PR
    BJU Int; 2008 Mar; 101(6):691-7. PubMed ID: 18291018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Transurethral high energy microwave (thermo-) therapy of benign prostatic hyperplasia].
    Urologe A; 1998 Jan; 37(1):111-2. PubMed ID: 9540197
    [No Abstract]   [Full Text] [Related]  

  • 17. An evaluation of the economic costs and patient-related consequences of treatments for benign prostatic hyperplasia.
    DiSantostefano RL; Biddle AK; Lavelle JP
    BJU Int; 2006 May; 97(5):1007-16. PubMed ID: 16542339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapeutic efficacy of bipolar plasmakinetic technique compared with transurethral resection on benign prostate hyperplasia].
    Wu WJ; Wang XH; Wang HP; Zou WB; Liang XY; Cai ZG; Zhong WW; Zou YF; Yuan DZ
    Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(47):3365-7. PubMed ID: 16409848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low morbidity following high dose rate brachytherapy in the setting of prior transurethral prostate resection.
    Peddada AV; Jennings SB; Faricy PO; Walsh RA; White GA; Monroe AT
    J Urol; 2007 Nov; 178(5):1963-7. PubMed ID: 17868718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of standard transurethral resection, transurethral vapour resection and holmium laser enucleation of the prostate for managing benign prostatic hyperplasia of >40 g.
    Kamat NN
    BJU Int; 2006 Oct; 98(4):918. PubMed ID: 16978299
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.